GlassScriptPhysician profile
Arezou Amidi
NPI 1992144398
$6,763.54
in general payments reported to CMS, 2019-2025
13 companies · $1,896 in 2025
The $1,896 reported for 2025 was more than what 89% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $579 · 2021: $522 · 2022: $3,630 · 2023: $30.42 · 2024: $107 · 2025: $1,896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,375 · Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,374.77 |
| Food and Beverage | $658.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,380.34 | 2022-2025 | |
| Summit Surgical Corp. | $1,604.26 | 2022 | |
| Stryker Corporation | $977.53 | 2023-2025 | Hoffmann, Augment Injectable, Pangea |
| Trilliant Surgical LLC. | $821.54 | 2020-2021 | |
| Invictus Surgical Incorporated | $340.65 | 2025 | |
| Treace Medical Concepts, INC. | $213.21 | 2020-2025 | |
| Smith+Nephew, INC. | $111.96 | 2021-2025 | Pico 7, Stravix Pl, Renasys Go V2 Home |
| Organogenesis INC. | $108.80 | 2024-2025 | Puraply Wound Matrix, Affinity |
| Zimmer Biomet Holdings, INC. | $68.74 | 2020 | |
| Orthofix Medical, INC. | $53.26 | 2020 | |
| Mimedx Group, INC. | $32.75 | 2025 | |
| Wright Medical Technology, INC. | $31.25 | 2020 | |
| Fusion Orthopedics USA, LLC | $19.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arezou Amidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.